NCT02078193View on ClinicalTrials.gov

Efficacy of Belatacept in Reducing DSA

PHASE4CompletedINTERVENTIONAL
Enrollment

3

Participants

Timeline

Start Date

November 30, 2013

Primary Completion Date

July 31, 2016

Study Completion Date

July 31, 2016

Conditions
Kidney Transplantation
Interventions
DRUG

Belatacept

Patients will be converted from their MMF to Belatacept

Trial Locations (1)

27834

East Carolina University, Greenville

All Listed Sponsors
lead

East Carolina University

OTHER

NCT02078193 - Efficacy of Belatacept in Reducing DSA | Biotech Hunter | Biotech Hunter